2 ms·
This is a combined phase 1/2 trial. It tests that the vaccine doesn't hurt or kill people too much, and that it has some immune system effect. After that a pha
by BurningFrog 6y ago
This is a combined phase 1/2 trial. It tests that the vaccine doesn't hurt or kill people too much, and that it has some immune system effect.
After that a phase 3 study is done on tens of thousands of people from all possible demographics.
- mathw 6y agoThat phase 3 study for the Oxford vaccine is already underway, and its initial findings are what the article is referring to. It was one of the first (possibly the first, I'm not entirely sure) to enter phase 3.